SuperworthKura Oncology shares outstanding KURA
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 88.9M
- On a year earlier
- +1.4%
- more shares
Kura Oncology had 88.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 88M | +1% |
| FY2024 | 87.1M | +13% |
| FY2023 | 77.3M | +14% |
| FY2022 | 67.8M | +2% |
| FY2021 | 66.6M | +13% |
| FY2020 | 58.8M | +30% |
| FY2019 | 45.3M | +19% |
| FY2018 | 38.1M | +30% |
| FY2017 | 29.2M | +53% |
| FY2016 | 19.2M | +25% |
| FY2015 | 15.3M | +205% |
| FY2014 | 5M | +0% |
| FY2013 | 5M | +0% |
| FY2012 | 5M | +0% |
| FY2011 | 5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 88.9M | +1% | |
| Q1 FY26 | 88.6M | +1% | |
| Q4 FY25 | 88M | +1% | |
| Q3 FY25 | 87.6M | +1% | |
| Q2 FY25 | 87.6M | +1% | |
| Q1 FY25 | 87.4M | +4% | |
| Q4 FY24 | 87.1M | +13% | |
| Q3 FY24 | 87M | +13% | |
| Q2 FY24 | 86.6M | +24% | |
| Q1 FY24 | 83.9M | +23% | |
| Q4 FY23 | 77.3M | +14% | |
| Q3 FY23 | 77.2M | +15% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Kura Oncology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.